Neural mechanisms of sex differences in vulnerability to the effects of adolescent methamphetamine exposure

NIH RePORTER · NIH · R21 · $178,833 · view on reporter.nih.gov ↗

Abstract

Project Summary Adolescence is a time of extensive neural reorganization, especially in the prefrontal cortex of both humans and rodents. One of the major changes that occurs in the medial prefrontal cortex is an increase in perineuronal nets (PNNs), an extracellular matrix that preferentially surrounds parvalbumin (PV)-expressing inhibitory interneurons, adding stability and functional support. Our recent data showed that female rats have a decrease in PNNs at puberty, which males do not, and this may result in greater female vulnerability to drug exposure during adolescence and at puberty. The premise of the current proposal is that the process of neural maturation of fast-spiking, inhibitory PV interneurons, and the formation of PNNs and their components in the medial prefrontal cortex, is an essential part of the vulnerability to substance use disorder during adolescence. This will be tested with exposure to a highly abused drug, methamphetamine (METH). Aim 1 will determine the short-term effects of METH exposure on both number and intensity of PV neurons and PNNs when administered at three separate time points: early-adolescence (overlapping with female puberty), late- adolescence (male puberty), or young adulthood. PV neurons, PNNs and their chondroitin sulfate proteoglycan components will be quantified immediately with the pubertal status noted. We hypothesize that there will be decreases in both PV intensity, the number of PNNs and their components, in the medial prefrontal of the adolescent-exposed, compared to an increase in the young adult-exposed. This effect would be indicative of the increased plasticity and resulting vulnerability to METH exposure in adolescence. We predict females in the young adolescent, pubertal group will be the most affected. Aim 2 will test animals that have been exposed to METH in Aim 1 and then are trained to self-administer METH as adults, followed by assessment of PV neurons, PNNs and their components. We predict that groups that were previously exposed as adolescents will exhibit greater escalation of intake and heightened motivation for METH that will be associated with greater increases in PNN expression, with the early adolescent-exposed females being most affected. The studies outlined here provide new avenues for future research on the impact of drug exposure during adolescence and its effects on the structure of the mPFC and later behavior, which in turn may inform the development of new treatment strategies.

Key facts

NIH application ID
10669275
Project number
5R21DA055105-02
Recipient
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
Principal Investigator
Joshua M Gulley
Activity code
R21
Funding institute
NIH
Fiscal year
2023
Award amount
$178,833
Award type
5
Project period
2022-08-01 → 2025-07-31